Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Mol Cancer Ther. 2016 Sep 26;15(12):2853–2862. doi: 10.1158/1535-7163.MCT-15-0789

Fig. 5. Intratumoral Injection of TPT in Combination with 177, 724, or 505 into Igrov1/T8 Xenografts.

Fig. 5

Igrov1/T8 cells were injected into the hind limbs of CB-17 SCID mice.(19) Once the cells had grown to the appropriate size range (50-250 mm3), TPT in conjunction with (A) 177, (B) 724, or (C) 505 was injected intratumorally. The size of the tumor mass was measured every 24 hours over a period of 120 hours. Average values with standard deviation for each compound are shown, n = 5. (D) The size of the tumor mass immediately prior to the first injection (0 hours) and the size at 120 hours were compared.